Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture

NEXT STORY
Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine
PREV STORY
Black Diamond Therapeutics Announces Appointment of Oncology Clinical Development Veteran Dr. Kapil Dhingra to Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aptose To Release First Quarter Ended March 31, 2018 Financial Results and Hold Conference Call on May 10, 2018

SAN DIEGO and TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) ...

author_avatar
NASDAQ Market News

TESARO Announces Definitive Agreement for $155 Million Private Placement

WALTHAM, Mass., Feb. 25, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

author_avatar
NASDAQ Market News

Health Plan Opens Doors to CDPHP Customer Connect

ALBANY, N.Y., April 22, 2016 (GLOBE NEWSWIRE) -- CDPHP has opened the doors to ...

author_avatar
NASDAQ Market News